Author

C. Jing

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biophysics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cell type annotation· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1

Frequent Co-Authors

A. C. Williams· 2 shared A. Y. Ye· 2 shared B. F. Haynes· 2 shared F. W. Alt· 2 shared H. Batra· 2 shared L. V. Francisco· 2 shared M. Tian· 2 shared S. Luo· 2 shared

Activity by Year

2020-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. C. Williams

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Humanized V(D)J-rearranging and TdT-expressing Mouse Vaccine Models with Physiological HIV-1 Broadly Neutralizing Antibody Precursors

S. Luo, C. Jing, A. Y. Ye, S. Kratochvil, C. A. Cottrell, J.-H. Koo, A. C. Williams, L. V. Francisco, H. Batra, E. Lamperti, O. Kalyuzhniy, Y. Zhang, A. Barbieri, J. P. Manis, B. F. Haynes, , F. W. Alt

This paper introduces new mouse models expressing human HIV-1 broadly neutralizing antibody (bnAb) precursors with more physiological levels and diversity, enhancing vaccine research for bnAb elicitation.

Proceedings of the National Academy of Sciences · Dec 27, 2022Peer-reviewedImmunology

Synthetic lethal targeting of TET2-mutant hematopoietic stem and progenitor cells by XPO1 inhibitors

C. Jing, N. Prutsch, S. He, M. W. Zimmerman, Y. Landesman, A. T. W. Look

This study identifies XPO1 inhibitors as selective killers of TET2-mutant HSPCs and AML cells through apoptosis, without DNA damage.

bioRxiv · Oct 12, 2022 · PreprintCancer Biology

Humanized antibody potently neutralizes all SARS-CoV-2 variants by a novel mechanism

S. Luo, J. Zhang, A. J. B. Kreutzberger, A. Eaton, R. J. Edwards, C. Jing, H.-Q. Dai, G. D. Sempowski, K. Cronin, R. Parks, A. Y. Ye, K. Mansouri, M. Barr, N. Pishesha, A. C. Williams, , F. W. Alt

The paper describes a humanized antibody, SP1-77, that neutralizes all SARS-CoV-2 variants by blocking membrane fusion instead of ACE2 receptor binding.

bioRxiv · Jun 26, 2022 · PreprintImmunology

Mitigation of radiation damage in macromolecules via tunable ultrafast stroboscopic TEM

H. Choe, I. Ponomarev, E. Montgomery, J. W. Lau, Y. Zhu, Y. Zhao, A. Liu, A. Kanareykin, C. Jing

This paper demonstrates a tunable ultrafast stroboscopic TEM system that reduces radiation damage in macromolecules by increasing critical dose at room temperature.

bioRxiv · May 15, 2020 · PreprintBiophysics